companydata.dkcompanydata.dk

Novo Nordisk Pharmatech A/S: Financial statements 2017

CVR: 13246149

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

Novo Nordisk Pharmatech A/S (CVR 13246149) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 622,436,000 and a net result of DKK 103,665,000 compared with DKK 87,367,000 the year before. That is a decrease of 7% compared with the year before. The profit margin was 16.7%. Equity in the 2017 report amounted to DKK 528,953,000. The solvency ratio was 78.2%. The company had 163 employees in the financial year.

Revenue
DKK 622,436,000
Gross Profit
DKK 263,449,000
Profit/Loss
DKK 103,665,000
Equity
DKK 528,953,000
Total Assets
DKK 676,372,000
Employees
163

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017622.4M263.4M103.7M529M163
2016669.1M238M87.4M468.3M158
2015505.2M228M92.1M400.9M150
2014495.2M176.6M55.3M336.8M150
2013498M170.7M46.7M304.5M141

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Novo Nordisk Pharmatech A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

Novo Nordisk Pharmatech A/S: The 2016 annual report is outMar 15, 2017

Novo Nordisk Pharmatech A/S has published its annual report for 2016. Revenue came to DKK 669,077,000, and the net result was DKK 87,367,000.

Claus Steensen Sølje joins the board of Novo Nordisk Pharmatech A/SJan 27, 2017

As of January 27, 2017, Claus Steensen Sølje has joined the board of directors of Novo Nordisk Pharmatech A/S.

About Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1989. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named FEF CHEMICALS A/S and FERROSAN FINE CHEMICALS A/S. The management consists of Ulla Grove Krogsgaard Thomsen. The board consists of Mette Sofie Mørck Jarl (chair), Christian Brøgger Stolberg, Jacob Sten Petersen and Joachim Juel Hagemeister. The company is owned by NOVO NORDISK A/S. The company has 489 employees (2026). In 2025, the company reported revenue of DKK 1,041,584,000 and a net result of DKK 113,891,000 compared with DKK 60,619,000 the year before. Equity in the 2025 report amounted to DKK 2,441,318,000.

Source: annual report 2025, Danish Business Authority